Triple-Negative Breast Cancer Treatment Market: Global Drivers, Restraints, Opportunities, Trends & Forecast to 2025
Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/14305
In most of the cases, after performing surgery chemotherapy treatment is given - adjuvant chemotherapy. In some cases, chemotherapy is given before surgery - neoadjuvant chemotherapy. In this treatment procedure, it helps in reduction of tumor size of breast cancer. About 10-20% of breast cancers cases are triple-negative breast cancers. Unmet need of triple-negative breast cancer is lack of proper interventions and treatment protocols. Few companies are trying to develop molecules that can treat triple-negative breast cancer conditions. For instance, Eribulin mesylate (Halaven®), developed by Eisai, completed clinical trials Phase 3 studies to treat triple-negative breast cancer conditions. In February 2016, Sacituzumab Govitecan (IMMU-132) got U.S. FDA breakthrough therapy designation for its treatment of triple-negative breast cancer conditions. IMMU-132 is an antibody-drug conjugate that acts by binding to protein Trop2 that overexpresses in triple breast cancer. Various other molecules are currently undergoing clinical trials to treat triple negative breast cancer.
According to the research article published in Journal of the Moffitt Cancer Center, around 1 million breast cancers are diagnosed globally among them 1.7% of cancer cases are triple-negative cancers. Triple-negative breast cancers are more aggressive and fewer survival rates when compared with breast cancer. Increase in incidence of breast cancers globally, and higher mortality rates related to breast cancers in developing countries are projected to driving the growth of this market during the forecast period. Lack of treatment regimens and proper drugs to treat this condition are hindering growth of this market.
Therapeutic area of triple-negative breast cancer treatment market was segmented into alkylating agents, natural products, antimetabolites and microtubule stabilizing agents. Alkylating agents is further segmented into Platinum coordination complexes. Natural products category is segmented into Plant products and Microorganism products.
Based on the route of administration, the triple-negative breast cancer treatment market was segmented into oral and parenteral. Parenteral route occupies the major market share followed by the oral route.
On the basis of the distribution channel, triple-negative breast cancer treatment market is segmented into hospital and retail pharmacies Hospital pharmacies accounts largest market share due to availability of these drugs in hospitals to treat breast cancer
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/14305
Based on the geographic region, triple-negative breast cancer treatment market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America occupies the major market share due to high research activities on triple-negative breast cancer, buying power of patients are the major factors boosting the growth of this market during the forecast period. Asia Pacific region is expected to grow with highest CAGR over the forecast period due to high incidence and mortality rates of breast cancer condition in this region.
Some of the players in triple-negative breast cancer treatment market include Celgene, Roche, Immunomedics GmbH, Merck & Co., Inc., F. Hoffmann-La Roche Ltd and Eisai Co., Ltd.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
Telephone - +1-646-568-7751
USA – Canada Toll Free: 800-961-0353
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Triple-Negative Breast Cancer Treatment Market: Global Drivers, Restraints, Opportunities, Trends & Forecast to 2025 here
News-ID: 947131 • Views: 212
More Releases from Persistence Market Research
The next decade to see the Hemodynamic Monitoring Systems Market reverberate dig …
The Hemodynamic Monitoring Systems Market is there to witness a placid CAGR of 5.3% between 2021-2031. Telehealth has turned out to be a boon - be it with remote monitoring or treating several patients at a distance simultaneously. The time as well stresses on the part of patients and physicians gets saved this way. Virtual follow-up also opens doors for multitasking by the healthcare personnel. This is the present and
Advancements in flow chemistry to drive the PVC Market
Polyvinyl chloride (PVC) is the third-most widely produced polymer, after polyethylene and polypropylene. PVC is one the most widely used plastics and is produced by polymerization of the monomer vinyl chloride. PVC has an amorphous structure with polar chlorine atoms and has fire retardant properties and oil/chemical resistance. PVC is widely used in construction, packaging, automotive and electrical industries due to the various properties such as light weight, good mechanical
Use of catalysts at nano-scale in chemical vertical to replenish the Adhesives M …
As stated by Persistence Market Research (PMR) through its various 'Chemicals' domain reports, it is expected - that many rebounding economies in the post Covid-19 era across the globe are bound to grow threefold in the next decade. The global hot melt adhesives market is anticipated to expand at a CAGR of 6.2% over the forecast period of 2021 and 2031. Significant growth of the packaging industry is boosting demand of
The Antibodies Contract Manufacturing Market to prove to be the digitized mouthp …
The Antibodies Contract Manufacturing Market is likely to grow voraciously, i.e. at a CAGR of 13% between 2021-2031. Augmented and virtual reality are abreast with advanced technologies on a significant count. VR and AR do have loads of potential for offering in the healthcare vertical. The application areas include surgery and training simulation, and patients care and treatment. As per Persistence Market Research's latest industry analysis, the global antibodies contract manufacturing
More Releases for Breast
Breast Reduction Bangalore
The Pros and Cons of a Breast Reduction: All of these symptoms can be a telltale sign your breasts are too heavy for your frame: Pressure on the shoulders caused by bra straps supporting too much weight. Severe back and neck pain. Numbness in your hands and fingers. Headaches. Shortness of breath. Breast reduction is a surgical procedure that reduces the size and weight of the breasts. It has proven to be a popular solution to alleviate
Soaring Instances of Breast Cancer to Propel Breast Imaging Market
"The Report Breast Imaging Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 - MarketResearchReports.biz" An intelligence report on the global breast imaging market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Breast Imaging Market (Mammography, Breast MRI, Breast Ultrasound, Tomosynthesis, Nuclear Imaging and Others [Breast Thermography & Bioelectric Imaging]) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” the
What Is A Combined Breast Augmentation With Breast Lift?
Combined Breast Augmentation And Lift: How Is It Performed? Surrounding the areola one incisions is made to remove the excess skin and another vertically incisions is made to the base of breasts starting from low part of the areola. Sometimes the scar is referred to as the “Lollipop scar”. Implants are placed through the incisions made and positioned carefully by the surgeon under the pectoral chest muscle, where the implants can
Global Breast Pumps Market
The Global Breast Pumps Market was valued at US$ 606.6 million in 2015 and is projected to expand at a CAGR of 4.8% during 2016–2024,according to a new report published by Coherent Market Insights. Rapidly growing population and improving insurance scenario is propelling demand for breast pumps worldwide. Demand for electronic breast pumps is gaining high traction in terms mainly due to adjustable suction level aiding ease of use. A more
Liposuction Breast Reduction
Portsmouth, NH - Liposuction Breast Reduction, also known as Scarless Breast Reduction continues to gain in popularity over the traditional method of breast reduction for the relief of back, neck and shoulder pain. More and more patients are dissatisfied with the older method and are requesting the less invasive method over the twelve inches of scarring per breast. Plastic Surgeons are responding to their patients and are performing more and
Breast Cancer-Breast Conservation Is A Possibility
New Delhi - April 27, 2011: The incidence of breast cancer is rapidly increasing in India and has overtaken cancer of cervix in Indian women in metropolitan cities. One in 22 Indian women are likely to develop breast cancer during their lifetime. Breast cancer is a disease of old age with the peak incidence in the fifth and sixth decades - but in India the disease is seen a decade